ICU MEDICAL INC/DE Total Assets

• ICU MEDICAL INC/DE showed a decrease of -3.6% in Total Assets from 2024 to 2025.
• This data is from ICU MEDICAL INC/DE's annual report (Form 10-K), filed with the SEC on February 19, 2026.
• XBRL data for this metric is available from 2008 to 2025 (18 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
• Quarterly values from 10-Q filings: Q1 2009: $294.02 million | Q2 2009: $299.07 million | Q3 2009: $310.45 million | Q1 2010: $286.90 million | Q2 2010: $286.67 million | Q3 2010: $300.42 million | Q1 2011: $329.20 million | Q2 2011: $346.33 million | Q3 2011: $343.51 million | Q1 2012: $376.48 million | Q2 2012: $392.59 million | Q3 2012: $412.91 million | Q1 2013: $437.88 million | Q2 2013: $451.56 million | Q3 2013: $468.68 million | Q1 2014: $506.43 million | Q2 2014: $519.52 million | Q3 2014: $527.72 million | Q1 2015: $554.34 million | Q2 2015: $570.24 million | Q3 2015: $610.23 million | Q1 2016: $635.96 million | Q2 2016: $663.38 million | Q3 2016: $688.70 million | Q1 2017: $1.47 billion | Q2 2017: $1.49 billion | Q3 2017: $1.52 billion | Q1 2018: $1.49 billion | Q2 2018: $1.53 billion | Q3 2018: $1.55 billion | Q1 2019: $1.61 billion | Q2 2019: $1.62 billion | Q3 2019: $1.64 billion | Q1 2020: $1.82 billion | Q2 2020: $1.86 billion | Q3 2020: $1.73 billion | Q1 2021: $1.77 billion | Q2 2021: $1.80 billion | Q3 2021: $1.84 billion | Q1 2022: $4.75 billion | Q2 2022: $4.59 billion | Q3 2022: $4.45 billion | Q1 2023: $4.47 billion | Q2 2023: $4.46 billion | Q3 2023: $4.38 billion | Q1 2024: $4.29 billion | Q2 2024: $4.29 billion | Q3 2024: $4.31 billion | Q1 2025: $4.18 billion | Q2 2025: $4.11 billion | Q3 2025: $4.10 billion.
• Over the full 18 years of available data (2008 to 2025), ICU MEDICAL INC/DE's Total Assets has grown by 1,329.1%.
• Historical annual values: Fiscal year 2025: $4.05 billion | Fiscal year 2024: $4.20 billion | Fiscal year 2023: $4.38 billion | Fiscal year 2022: $4.52 billion | Fiscal year 2021: $1.88 billion | Fiscal year 2020: $1.76 billion | Fiscal year 2019: $1.69 billion | Fiscal year 2018: $1.59 billion | Fiscal year 2017: $1.50 billion | Fiscal year 2016: $704.69 million | Fiscal year 2015: $626.83 million | Fiscal year 2014: $541.10 million | Fiscal year 2013: $499.64 million | Fiscal year 2012: $428.51 million | Fiscal year 2011: $361.11 million | Fiscal year 2010: $309.64 million | Fiscal year 2009: $309.15 million | Fiscal year 2008: $283.43 million.
• Data sourced from SEC EDGAR public filings as of August 5, 2026.

Last verified: August 5, 2026